Age and Activity-Dependent Differences in Intraocular Immune Profile of Chronic Autoimmune Uveitis 2259109

E Eamon Winden (Boston Children’s Hospital) M Maryrose Hahn (Boston Children’s Hospital) Y Yang Yang M Madison Mangin (Boston Children’s Hospital) K Kellen Winden (Boston Children’s Hospital) P Pui Lee (Boston Children’s Hospital) M Mindy Lo (Boston Children’s Hospital) Y Yasmin Massoudi (Massachusetts Eye Research and Surgery Institution; The Ocular Immunology and Uveitis Foundation) T Tate Valerio (Massachusetts Eye Research and Surgery Institution; The Ocular Immunology and Uveitis Foundation) A Amanda Colombo (Massachusetts Eye Research and Surgery Institution; The Ocular Immunology and Uveitis Foundation) J Jessica Scott (Massachusetts Eye Research and Surgery Institution; The Ocular Immunology and Uveitis Foundation) S Stephen Anesi (Massachusetts Eye Research and Surgery Institution; The Ocular Immunology and Uveitis Foundation) C C Stephen Foster (Massachusetts Eye Research and Surgery Institution; The Ocular Immunology and Uveitis Foundation) P Peter Nigrovic (Boston Children’s Hospital/Brigham and Women’s Hospital) B Bharti Nihalani-Gangwani (Boston Children’s Hospital) S Sheila Angeles-Han (Cincinnati Children’s Hospital Medical Center; Abrahamson Pediatric Eye Institute; University of Cincinnati) P Peter Chang (2Tampa General Hospital, Tampa, United States) M Margaret Chang (Boston Children’s Hospital)

Abstract

Abstract Introduction Autoimmune uveitis is a chronic inflammatory disorder of the eye. Uveitis relapse occurs in 85% of patients who discontinue medications, necessitating lifelong immunosuppression, yet the pathogenesis of chronic, relapsing eye inflammation is poorly understood. Methods We obtained intraocular aqueous humor (AQH) samples from patients with clinically inactive uveitis (n = 29) or non-inflammatory controls (n = 16) undergoing eye surgery. Olink proteomic profiling and 10X single-cell RNA sequencing were performed on each sample. Results 41% of all uveitis patients displayed subclinical elevation of inflammatory cytokines within their eyes. Even more striking, >85% of children had subclinical immune activity. Single-cell RNA sequencing revealed distinct immune cell populations associated with patient age and clinical disease activity. Namely, we found a higher prevalence of monocytes in adult uveitis, with none detected in pediatric samples. This was supported by proteomic data as well, which showed an association with adult uveitis and myeloid-related inflammatory cytokines. There was no correlation between monocytes and disease activity. In contrast, subclinical immune activity was associated with increased CD8+ T cells, specifically resident memory T cells (TRM), and decreased CD4+ T cell populations. Proteomic analysis confirmed a direct correlation between IL-15, which supports CD8+ T cells and TRM survival, and subclinical disease activity. Conclusion Our results provide further insights into chronic autoimmune uveitis, highlighting distinctions between pediatric and adult disease and activity-dependent immunity in the ocular microenvironment. Funding Source Rheumatology Research Foundation and Joint Biology Consortium microgrant off parent grant NIH/NIAMS P30AR070253 Topic Categories Immune Mechanisms of Human Disease (HUM)

Article Details

Volume / Issue Vol. 215, Issue Supplement_1
Published August 01, 2026
ISSN 0022-1767
Publisher American Association of Immunologists

Authors (18)

E

Eamon Winden

Boston Children’s Hospital

M

Maryrose Hahn

Boston Children’s Hospital

Y

Yang Yang

M

Madison Mangin

Boston Children’s Hospital

K

Kellen Winden

Boston Children’s Hospital

P

Pui Lee

Boston Children’s Hospital

M

Mindy Lo

Boston Children’s Hospital

Y

Yasmin Massoudi

Massachusetts Eye Research and Surgery Institution; The Ocular Immunology and Uveitis Foundation

T

Tate Valerio

Massachusetts Eye Research and Surgery Institution; The Ocular Immunology and Uveitis Foundation

A

Amanda Colombo

Massachusetts Eye Research and Surgery Institution; The Ocular Immunology and Uveitis Foundation

J

Jessica Scott

Massachusetts Eye Research and Surgery Institution; The Ocular Immunology and Uveitis Foundation

S

Stephen Anesi

Massachusetts Eye Research and Surgery Institution; The Ocular Immunology and Uveitis Foundation

C

C Stephen Foster

Massachusetts Eye Research and Surgery Institution; The Ocular Immunology and Uveitis Foundation

P

Peter Nigrovic

Boston Children’s Hospital/Brigham and Women’s Hospital

B

Bharti Nihalani-Gangwani

Boston Children’s Hospital

S

Sheila Angeles-Han

Cincinnati Children’s Hospital Medical Center; Abrahamson Pediatric Eye Institute; University of Cincinnati

P

Peter Chang

2Tampa General Hospital, Tampa, United States

M

Margaret Chang

Boston Children’s Hospital